In an interview at ACG 2019, William Sandborn, MD, chief of the division of gastroenterology at University of California, San Diego, and ustekinumab clinical trial investigator, discusses the recent FDA approval for ulcerative colitis and shares research on the effects of the maintenance regimen on histologic and endoscopic activity.
21 окт 2024